Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Prenatal glycemic control as a predictor of childhood obesity among offspring of women with type 2 diabetes

EF 2022-23

Résumé
The prevalence of type 2 diabetes in pregnancy is on the rise. Young women with type 2 diabetes often have higher rates socioeconomic deprivation and are under-represented in the literature. Their children are also more likely to develop diabetes and obesity. Thus, it is important for clinicians to identify prenatal risk factors for obesity, to allow for effective counselling and to design interventions to stop this vicious cycle. My research question is: does the mother’s blood sugar control in pregnancy, as measured by hemoglobin A1c (HbA1c), predict the risk of her child being overweight or obese at 2 years of age? My proposed study uses data collected as part of a clinical trial and its follow-up study to answer this question. The Metformin in Women with Type 2 Diabetes in Pregnancy Trial (MiTy) was a study involving 502 pregnant women with type 2 diabetes. Participants were randomly assigned to receive either metformin or placebo in addition to insulin during pregnancy. MiTy Kids is the follow-up study of MiTy, in which 283 children of consenting mothers were followed for 24 months from birth to determine whether metformin exposure affected childhood adiposity. All participants of MiTy Kids will be included in our study. The primary predictor of interest will be HbA1c in third trimester. Secondary predictors include fasting glucose and 2-hr postprandial glucose, which were collected on a subset of women in MiTy. The primary outcome will be overweight or obesity at 2 years of age. Secondary outcomes are BMI z-score and other measures of adiposity. By establishing a clear association between HbA1c in pregnancy and risk of childhood adiposity, we hope to better counsel women with type 2 diabetes in pregnancy in ways to lower the risk of obesity in their children.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486365
Name
Fu Jennifer R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Prenatal glycemic control as a predictor of childhood obesity among offspring of women with type 2 diabetes
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Glycemic Control; Pediatric Obesity; Pregnancy; Pregnancy In Diabetics; Prenatal Exposure Delayed Effects; Type 2 Diabetes
Abstract
The prevalence of type 2 diabetes in pregnancy is on the rise. Young women with type 2 diabetes often have higher rates socioeconomic deprivation and are under-represented in the literature. Their children are also more likely to develop diabetes and obesity. Thus, it is important for clinicians to identify prenatal risk factors for obesity, to allow for effective counselling and to design interventions to stop this vicious cycle. My research question is: does the mother’s blood sugar control in pregnancy, as measured by hemoglobin A1c (HbA1c), predict the risk of her child being overweight or obese at 2 years of age? My proposed study uses data collected as part of a clinical trial and its follow-up study to answer this question. The Metformin in Women with Type 2 Diabetes in Pregnancy Trial (MiTy) was a study involving 502 pregnant women with type 2 diabetes. Participants were randomly assigned to receive either metformin or placebo in addition to insulin during pregnancy. MiTy Kids is the follow-up study of MiTy, in which 283 children of consenting mothers were followed for 24 months from birth to determine whether metformin exposure affected childhood adiposity. All participants of MiTy Kids will be included in our study. The primary predictor of interest will be HbA1c in third trimester. Secondary predictors include fasting glucose and 2-hr postprandial glucose, which were collected on a subset of women in MiTy. The primary outcome will be overweight or obesity at 2 years of age. Secondary outcomes are BMI z-score and other measures of adiposity. By establishing a clear association between HbA1c in pregnancy and risk of childhood adiposity, we hope to better counsel women with type 2 diabetes in pregnancy in ways to lower the risk of obesity in their children.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fu, Jennifer R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~